Sun Life Financial
A high-ROE, diversified insurer-plus-asset-manager — insurance, MFS/SLC asset management and U.S. group benefits under one roof.
The business
Sun Life spans individual insurance, a large asset-management arm (MFS Investment Management and SLC Management), Canadian and U.S. group benefits (including DentaQuest dental), and a growing Asia business.
The asset-management and group-benefits mix makes it more fee-oriented and capital-light than a pure life insurer.
The moat
A diversified, partly capital-light model — asset management and group benefits add stable fee streams to the insurance base.
MFS is a scaled, profitable global asset manager.
Related on CoinCompass: Retirement drawdown calculator · Guides. For the underlying numbers, see Sun Life Q1 2026 results (Sun Life).
Financial snapshot
Most recent reported period : Q1 FY2026 (ended March 31, 2026). Figures reflect the review date — confirm current numbers before acting.
| Underlying net income | C$1.05B |
| Underlying EPS | C$1.89 (+4% YoY) |
| Underlying ROE | 18.6% |
| Reported ROE | 8.2% |
| Dividend yield | ~3.7% (dividend +4%) |
Free cash flow yield & sustainable growth
Earnings yield : ≈4.6%≈ earnings yield (trailing P/E ~21.7)
As with any insurer, free cash flow isn't the right yardstick — Sun Life is measured on underlying ROE, underlying EPS growth and dividend coverage.
Its underlying ROE of 18.6% is among the best in the sector, and the fee-heavy asset-management/group-benefits mix makes those returns less capital-intensive to sustain.
Sustainable growth: mid-single-digit-plus underlying EPS growth from asset management, group benefits and Asia, supported by regular dividend increases.
Valuation & what to watch
Sun Life is judged on underlying earnings and ROE, not free cash flow. It typically commands a premium to Manulife on its higher-quality, higher-ROE, more fee-based mix.
The gap between an 18.6% underlying ROE and an 8.2% reported ROE is the key thing to understand — the difference is market-driven noise, not operating weakness.
Dividend
Announced a 4% dividend increase (yield ~3.7%), backed by a high underlying ROE and diversified, partly fee-based earnings.
Risks & the bear case
- MFS asset-management net flows and AUM levels drive a big chunk of fee earnings.
- U.S. group/dental (DentaQuest) exposure to Medicaid redetermination and utilization.
- Interest-rate and equity-market sensitivity.
- Reported earnings can diverge sharply from underlying on market moves.
Recent developments
Q1 FY2026 underlying net income of C$1.05B and underlying EPS of C$1.89 (+4%), with an 18.6% underlying ROE and a 4% dividend increase.
Verdict
The higher-quality Canadian life-and-wealth name: a top-tier underlying ROE and a diversified, partly fee-based model. The bull case is durable high returns plus steady dividend growth; the bear case is MFS outflows and U.S. dental. Conviction: a quality core holding, usually priced for it.
Sources
CoinCompass is a publisher, not a registered investment adviser. This is factual information and opinion for a general audience — not a recommendation to buy or sell any security, and not individualized advice. Figures are the most recent reported at the review date and will change. The author, John Wilson, has disclosed long-term holdings in Canadian equities (including Boyd Group, Constellation Software and MTY Food Group) and may hold positions in securities discussed. Do your own research or consult a licensed professional. See our disclosures. John Wilson → · disclosures →